Drug survival of apremilast in patients treated for psoriasis in a real-world setting

被引：19
|
作者：
Lee, Erica B. [1 ]
Amin, Mina [2 ,4 ]
Wu, Jashin J. [3 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA
[3] Kaiser Permanente Los Angeles, Dept Dermatol, Med Ctr, 1515 North Vermont Ave,5th Floor, Los Angeles, CA 90027 USA
[4] Kaiser Permanente Los Angeles, Dept Med, Med Ctr, Los Angeles, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 04期
关键词：
ORAL PHOSPHODIESTERASE-4 INHIBITOR; SEVERE PLAQUE PSORIASIS; CONTROLLED-TRIAL; PHASE-III; EFFICACY; MODERATE; SAFETY;
D O I：
10.1016/j.jaad.2018.03.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：760 / 761
页数：3
相关论文
共 50 条
  • [21] Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
    Torres, Tiago
    Balato, Anna
    Conrad, Curdin
    Conti, Andrea
    Dapavo, Paolo
    Ferreira, Paulo
    Gaiani, Francesca
    Leite, Luiz
    Malagoli, Piergiorgio
    Mendes-Bastos, Pedro
    Megna, Matteo
    Messina, Francesco
    Nidegger, Alessia
    Odorici, Giulia
    Piaserico, Stefano
    Prignano, Francesca
    Ribero, Simone
    Ricceri, Federica
    Tonini, Annalisa
    Valerio, Joana
    Chiricozzi, Andrea
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 273 - 275
  • [22] Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
    Saal, Ryan C.
    Alnaif, Sarah
    Edwards, Joshua F.
    Wintringham, Jennifer A.
    Smith, Robert J.
    JAAD INTERNATIONAL, 2023, 11 : 209 - 210
  • [23] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
    Ohata, Chika
    Ohyama, Bungo
    Kuwahara, Fumi
    Katayama, Eri
    Nakama, Takekuni
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
  • [24] Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
    De, Abhishek
    Das, Sudip
    Dhoot, Dhiraj
    Sarda, Aarti
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (05) : 396 - 400
  • [25] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
    Ohata, Chika
    Ohyama, Bungo
    Kuwahara, Fumi
    Katayama, Eri
    Nakama, Takekuni
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 383 - 386
  • [26] Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
    Iznardo, H.
    Vilarrasa, E.
    Lopez-Ferrer, A.
    Puig, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : 660 - 662
  • [27] Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan
    Kishimoto, Megumi
    Komine, Mayumi
    Kamiya, Koji
    Sugai, Junichi
    Mieno, Makiko
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2020, 47 (01): : 33 - 40
  • [28] The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
    Rajagopalan, Murlidhar
    Dogra, Sunil
    Saraswat, Abir
    Varma, Sachin
    Banodkar, Pravin
    PSORIASIS-TARGETS AND THERAPY, 2021, 11 : 109 - 122
  • [29] Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world setting
    Cavanaugh, Cristi
    Orroth, Kate
    Qian, Xi
    Kumparatana, Pam
    Klyachkin, Yuri
    Colgan, Stephen
    Cordey, Myriam
    JAAD INTERNATIONAL, 2024, 16 : 244 - 251
  • [30] Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis
    Van Muijen, Marloes E.
    Thomas, Sarah E.
    Vellinga, Douwe
    Bouwman, Silke
    Van Doorn, Martijn B. A.
    Politiek, Klaziena
    Otero, Marisol E.
    Van den Reek, Juul M. P. A.
    De Jong, Elke M. G. J.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
12345